Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 9, 2007, Pages 1140-1144

  Dimitrijevic Sreckovic, Vesna ^a,b   Colak, Emina ^a   Djordjevic, Predrag ^a   Gostiljac, Drasko ^a   Sreckovic, Branko ^a   Popovic, Srdjan ^a   Canovic, Fadil ^a   Ilic, Miroljub ^a   Obrenovic, Radmila ^a   Vukcevic, Vladan ^a   Nikolic, Dragan ^a   Nisic, Tanja ^a   Milic, Gordana ^a   Pejcic, Gordana ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b NONE

Author keywords

Antioxidative defense; Children adolescents; Metabolic syndrome; Plasminogen activator inhibitor l; Pre metabolic syndrome

Indexed keywords

FIBRINOGEN; GLUTATHIONE PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; SUPEROXIDE DISMUTASE;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; METABOLIC SYNDROME X; MODEL; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ANTIOXIDANTS; BODY MASS INDEX; CHILD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 34548555884     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.259     Document Type: Article

References (23)

1. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep 2004;4:53-62.
2. Raitakari OT, Porkka KV, Ronnemaa T, Knip M, Uhari M, Akerblom HK, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The cardiovascular risk in Young Finns Study. Diabetologia 1995;38:1042-50.
3. Weiss R, Caprio S. Altered glucose metabolism in obese youth. Pediatr Endocrinol Rev 2006;3:233-9.
4. Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308-14.
5. Colak E, Majkic-Singh N, Stankovic S, Dimitrijevic-Sreckovic V, Djordjevic P, Lalic K, et al. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 2005;37:613-20.
6. Bastard JP, Pieroni L, Hanique B. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev 2000;16:192-201.
7. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care 2002;25:(Suppl 1):S1-147.
8. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002;246:1-190.
9. Katzmarzyk PT, Srinivasan SR, Chen W, Malina RM, Bouchard C, Berenson GS. Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics 2004;114:198-205.
10. McCarthy HD, Ellis SM, Cole TJ. Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference. Br Med J 2003;326:624.
11. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7.
12. Haffner SM, Miettinen H, Stern M. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087-92.
13. Weghuber D, Roen M, Tura A. Prevalence of insulin resistance in morbid obesity in young Europeans wabstractx. Aktuelle Ernährungsmedizin 2004;29:A93.
14. Weiss R, Dziura J, Burgert TS, Tamborlanc WV, Taksali SE, Yeckel CW. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
15. Barclay L. Waist circumference may predict insulin resistance syndrome in children. Arch Pediatr Adolesc Med 2005;159:740-4.
16. Gomez-Diaz RA, Martinez-Hernandez AJ, Aquilar-Salinas CA, Violante R, Lopez-Alarcon M, Jimenez-Villarruel M, et al. Percentile distribution of the waist circumference among Mexican preadolescents in primary school in Mexico city. Diab Obes Met 2005;7:716-21.
17. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M. Platelet activation in obese women: role of inflammation and oxidant stress. J Am Med Assoc 2002;288:2008-14.
18. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med 2006;6:501-14.
19. Keaney JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Atherioscler Thromb Vasc Biol 2003;23:434-9.
20. Goupal NK, Manray MD, Hebe A, Lee Kwai Yan S, Johnston A, Carrier MJ, et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 2004;44:706-12.
21. Dimitrijevic Sreckovic SV, Djordjevic PB, Popovic SS, Gostiljac D, Canovic F, Sreckovic MB, et al. Metabolic syndrome and antioxidative activity in early glycoregulation disorders [abstract]. Diabetologia 2004;47(Suppl 1):A143.
22. Invitti C, Maffeis C, Gilardini L, Pontigia B, Mazzilli G, Girola A, et al. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes 2006;30:627-33.
23. Juhan-Vague I, Alessi MC, Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin dependent diabetes mellitus. Ann Med 1996;28:371-80.